Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study.
about
CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African WomenPopulation Pharmacokinetic Model Linking Plasma and Peripheral Blood Mononuclear Cell Concentrations of Efavirenz and Its Metabolite, 8-Hydroxy-Efavirenz, in HIV Patients.CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.The pharmacological challenges of treating tuberculosis and HIV coinfections.Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high HIV and tuberculosis burden countries: a systematic review.Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype
P2860
Q36966640-8AE78792-8948-4054-8580-DAC481D3166DQ38755666-E101DCB8-9AF0-41FE-9EB9-95E1A43650BDQ38855121-4958CC25-8BA7-4C8C-9FC7-9315A1E806A9Q39003762-B02F4B80-A54A-471E-8D5D-E49B5D26B10DQ40563423-E4BBD07A-4868-4AE6-811C-6771B1890D19Q52330065-35DCB58D-AFDE-4A00-AF34-132EDFC15430Q58612379-E904E215-F633-4C98-8112-DFCDCD6D5801
P2860
Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@en
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@nl
type
label
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@en
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@nl
prefLabel
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@en
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Is there a need to increase th ...... ? The HIV-TB pharmagene study.
@en
P2093
Abiy Habtewold
Getachew Aderaye
Wondwossen Amogne
P2860
P304
P356
10.2217/PGS.15.35
P577
2015-04-01T00:00:00Z